Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Angew Chem Int Ed Engl ; : e202408514, 2024 Jul 02.
Article in English | MEDLINE | ID: mdl-38954391

ABSTRACT

Electron transfers in multinuclear metal complexes are the origin of their unique functionalities both in natural and artificial systems. However, electron transfers in multinuclear metal complexes are generally complicated, and predicting and controlling these electron transfers is extremely difficult. Herein, we report the precise manipulation of the electron transfers in multinuclear metal complexes. The development of a rational synthetic strategy afforded a series of pentanuclear metal complexes which composed of metal ions and 3,5-bis(2-pyridyl)pyrazole (Hbpp) as a platform to probe the phenomena. Electrochemical and spectroscopic investigations clarified overall picture of the electron transfers in the pentanuclear complexes. In addition, unique electron transfer behaviors, in which the reduction of a metal center occurs during the oxidation of the overall complex, were identified. We also elucidated the two dominant factors that determine the manner of the electron transfers. Our results provide comprehensive guidelines for interpreting the complicated electron transfers in multinuclear metal complexes.

2.
Dalton Trans ; 49(5): 1384-1387, 2020 Feb 07.
Article in English | MEDLINE | ID: mdl-31939972

ABSTRACT

A pentanuclear cobalt complex that consists of five cobalt ions and six bpp- ligands (Co5, Hbpp = 3,5-bis(2-pyridyl)pyrazole) was synthesized and crystallographically characterized. Electrochemical measurements indicate that Co5 has multielectron transfer ability. We also found that Co5 reduces CO2 to CO under photoirradiation in the presence of a photosensitizer.

3.
J Am Chem Soc ; 140(49): 16899-16903, 2018 12 12.
Article in English | MEDLINE | ID: mdl-30472827

ABSTRACT

Visible-light-driven catalytic reduction of CO2 is at the heart of artificial photosynthesis. Here, we demonstrate the first example of a Ru complex that can function both as a photosensitizer and catalyst for CO2 reduction. The catalyst exhibited excellent activity for CO evolution with a high turnover number (TON, 353 for 24 h), reaction rate (TOF, 14.7 h-1), and product selectivity (97%) under visible-light irradiation. We also succeeded in selective product formation (CO or HCOOH) by changing the basicity of the reaction media. This finding will open new avenues for visible-light-driven photoredox catalysis using Ru-based function-integrated photocatalysts.

4.
Chem Commun (Camb) ; 54(50): 6915-6918, 2018 Jun 19.
Article in English | MEDLINE | ID: mdl-29850662

ABSTRACT

A Ru polypyridyl complex containing a phosphine donor promoted electrocatalytic CO2 reduction at a low overpotential. Mechanistic investigations revealed that the introduction of a phosphine donor at the trans position to the labile ligand is the key to reduce the overpotential for CO2 reduction.

5.
J Biol Inorg Chem ; 22(5): 713-725, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28083656

ABSTRACT

The construction of molecular catalysts that are active toward CO2 reduction is of great significance for designing sustainable energy conversion systems. In this study, we aimed to develop catalysts for CO2 reduction by introducing aromatic substituents to the meso-positions of iron porphyrin complexes. Three novel iron porphyrin complexes with π-expanded substituents (5,10,15,20-tetrakis(pyren-1-yl)porphyrinato iron(III) chloride (Fe-Py)), π-extended substituents (5,10,15,20-tetrakis((1,1'-biphenyl)-4-yl)porphyrinato iron(III) chloride (Fe-PPh)) and π-expanded and extended substituents (5,10,15,20-tetrakis(4-(pyren-1-yl)phenyl)porphyrinato iron(III) chloride (Fe-PPy)) were successfully synthesized, and their physical properties were investigated by UV-vis absorption spectroscopy and electrochemical measurements under Ar in comparison with an iron complex with a basic framework, 5,10,15,20-tetrakis(phenyl)porphyrinato iron(III) chloride (Fe-Ph). Moreover, the catalytic activity of the complexes was studied by electrochemical measurements under CO2, and it is found that the complex with the π-expanded substituents exhibits the highest activity among these complexes.


Subject(s)
Carbon Dioxide/chemistry , Iron/chemistry , Metalloporphyrins/chemistry , Metalloporphyrins/chemical synthesis , Porphyrins/chemistry , Molecular Structure , Oxidation-Reduction
6.
J Inorg Biochem ; 159: 14-21, 2016 06.
Article in English | MEDLINE | ID: mdl-26901628

ABSTRACT

Three transition metal derivatives (Zn, Cu, and Ni) of 2-[2-bromoethyliminomethyl]-4-[ethoxymethyl]phenol (L) were synthesized by the reaction of the metal salts with the Schiff base ligand in one pot. In the crystal structure of [Zn(L)Br], the Schiff base ligand binds to the metal center through its phenolate oxygen and imine nitrogen, and adopts a distorted tetrahedral geometry. These compounds were found to inhibit topoisomerase I (topo I) activity, induce DNA cleavage and show DNA binding activity. Moreover, these compounds were found to be cytotoxic towards several cancer cell lines (A2780, MCF-7, HT29, HepG2, A549, PC3, LNCaP) and prevent metastasis of PC3. Collectively, Cu(II) complex 2 shows superior activity relative to its Zn(II) and Ni(II) analogs.


Subject(s)
Antineoplastic Agents , Cell Proliferation/drug effects , Copper , DNA, Bacterial/metabolism , Escherichia coli/metabolism , Neoplasms , Nickel , Organometallic Compounds , Topoisomerase I Inhibitors , Zinc , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Cell Line, Tumor , Copper/chemistry , Copper/pharmacology , Escherichia coli/genetics , Humans , Neoplasm Metastasis , Neoplasms/drug therapy , Neoplasms/metabolism , Nickel/chemistry , Nickel/pharmacology , Organometallic Compounds/chemical synthesis , Organometallic Compounds/chemistry , Organometallic Compounds/pharmacology , Topoisomerase I Inhibitors/chemical synthesis , Topoisomerase I Inhibitors/chemistry , Topoisomerase I Inhibitors/pharmacology , Zinc/chemistry , Zinc/pharmacology
7.
Dalton Trans ; 44(39): 17189-200, 2015 Oct 21.
Article in English | MEDLINE | ID: mdl-26373342

ABSTRACT

Four novel phosphine-substituted ruthenium(ii) polypyridine complexes with nitrogen oxides-trans(P,NO2)-[Ru(trpy)(Pqn)(NO2)]PF6 (trans-NO2), cis(P,NO2)-[Ru(trpy)(Pqn)(NO2)]PF6 (cis-NO2), [Ru(trpy)(dppbz)(NO2)]PF6 (PP-NO2), and cis(P,NO)-[Ru(trpy)(Pqn)(NO)](PF6)3 (cis-NO)-were synthesised (trpy = 2,2':6',2''-terpyridine, Pqn = 8-(diphenylphosphanyl)quinoline, and dppbz = 1,2-bis(diphenylphosphanyl)benzene). The influence of the number and position of the phosphine group(s) on the electronic structure of these complexes was investigated using single-crystal X-ray structural analysis, UV-vis absorption spectroscopy, and electrochemical measurements. The substitution lability of the nitrogen oxide ligand of each complex is discussed in comparison with that of the corresponding acetonitrile complexes.


Subject(s)
Nitrogen Oxides/chemical synthesis , Phosphines/chemical synthesis , Pyridines/chemical synthesis , Ruthenium/chemistry , Crystallography, X-Ray , Molecular Structure , Nitrogen Oxides/metabolism , Phosphines/metabolism , Pyridines/metabolism , Ruthenium/metabolism
8.
Eur J Med Chem ; 76: 397-407, 2014 Apr 09.
Article in English | MEDLINE | ID: mdl-24602785

ABSTRACT

Four new copper(II) complexes containing phosphonium substituted hydrazone (L) with the formulations [CuL]Cl(3), [Cu(phen)L]Cl(4), [Cu(bpy)L]Cl(5), [Cu(dbpy)L]Cl(6), (where L = doubly deprotonated hydrazone; phen = 1,10'-phenanthroline; bpy = 2,2'-bipyridine; dbpy = 5,5'-dimethyl-2,2'-bipyridine) have been synthesized. The compounds were characterized by elemental analysis, spectroscopic methods and in the case of crystalline products by X-ray crystallography. The cytotoxicity and topoisomerase I (topo I) inhibition activities of these compounds were studied. It is noteworthy that the addition of N,N-ligands to the copper(II) complex lead to the enhancement in the cytotoxicity of the compounds, especially against human prostate adenocarcinoma cell line (PC-3). Complex 4 exhibits the highest activity against PC-3 with the IC50 value of 3.2 µΜ. The complexes can also inhibit topo I through the binding to DNA and the enzyme.


Subject(s)
Copper/chemistry , Hydrazones/chemistry , Hydrazones/pharmacology , Phosphorus/chemistry , Topoisomerase I Inhibitors/chemistry , Topoisomerase I Inhibitors/pharmacology , Cell Line, Tumor , Crystallography, X-Ray , Drug Screening Assays, Antitumor , Humans , Ligands , Magnetic Resonance Spectroscopy , Models, Molecular , Spectrophotometry, Infrared
9.
Article in English | MEDLINE | ID: mdl-24231745

ABSTRACT

A cationic Schiff base ligand, TSB (L) and its Zn (II) complex (1) were synthesized and characterized by using CHN, (1)H-NMR, FT-IR, UV, LC-MS, and X-ray methods. Their ability to inhibit topoisomerase I, DNA cleavage activities, and cytotoxicity were studied. X-ray diffraction study shows that the mononuclear complex 1 is four coordinated with distorted tetrahedral geometry. The singly deprotonated Schiff base ligand L acts as a bidentate ON-donor ligand. Complexation of L increases the inhibitory strength on topoisomerase I activity. Complex 1 could fully inhibit topoisomerase I activity at 250 µM, while L did not show any inhibitory effect on topoisomerase I activity. In addition, L and complex 1 could cleave pBR322 DNA in a concentration and time dependent profile. Surprisingly, L has better DNA cleavage activity than complex 1. The cleavage of DNA by complex 1 is altered in the presence of hydrogen peroxide. Furthermore, L and complex 1 are mildly cytotoxic towards human ovarian cancer A2780 and hepatocellular carcinoma HepG2.


Subject(s)
Schiff Bases/chemical synthesis , Schiff Bases/pharmacology , Zinc/pharmacology , Cations , Cell Death/drug effects , Cell Line, Tumor , Crystallography, X-Ray , DNA Topoisomerases, Type I/metabolism , Electrons , Electrophoresis, Agar Gel , Humans , Hydrogen Bonding/drug effects , Ligands , Magnetic Resonance Spectroscopy , Molecular Conformation , Schiff Bases/chemistry , Schiff Bases/toxicity , Spectrophotometry, Infrared , Topoisomerase Inhibitors/pharmacology , Zinc/toxicity
SELECTION OF CITATIONS
SEARCH DETAIL
...